Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Lima JJ, Thomas CD, Barbarino J, Desta Z, Van Driest SL, El Rouby N, Johnson JA, Cavallari LH, Shakhnovich V, Thacker DL, Scott SA, Schwab M, Uppugunduri CRS, Formea CM, Franciosi JP, Sangkuhl K, Gaedigk A, Klein TE, Gammal RS, Furuta T. Lima JJ, et al. Among authors: barbarino j. Clin Pharmacol Ther. 2021 Jun;109(6):1417-1423. doi: 10.1002/cpt.2015. Epub 2020 Sep 20. Clin Pharmacol Ther. 2021. PMID: 32770672 Free PMC article.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
Amstutz U, Henricks LM, Offer SM, Barbarino J, Schellens JHM, Swen JJ, Klein TE, McLeod HL, Caudle KE, Diasio RB, Schwab M. Amstutz U, et al. Among authors: barbarino j. Clin Pharmacol Ther. 2018 Feb;103(2):210-216. doi: 10.1002/cpt.911. Epub 2017 Nov 20. Clin Pharmacol Ther. 2018. PMID: 29152729 Free PMC article.
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.
Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, Wang D, Vinks AA, He Y, Swen JJ, Leeder JS, van Schaik R, Thummel KE, Klein TE, Caudle KE, MacPhee IA. Birdwell KA, et al. Among authors: barbarino jm. Clin Pharmacol Ther. 2015 Jul;98(1):19-24. doi: 10.1002/cpt.113. Epub 2015 Jun 3. Clin Pharmacol Ther. 2015. PMID: 25801146 Free PMC article.
PharmGKB: A worldwide resource for pharmacogenomic information.
Barbarino JM, Whirl-Carrillo M, Altman RB, Klein TE. Barbarino JM, et al. Wiley Interdiscip Rev Syst Biol Med. 2018 Jul;10(4):e1417. doi: 10.1002/wsbm.1417. Epub 2018 Feb 23. Wiley Interdiscip Rev Syst Biol Med. 2018. PMID: 29474005 Free PMC article. Review.
PharmGKB summary: very important pharmacogene information for UGT1A1.
Barbarino JM, Haidar CE, Klein TE, Altman RB. Barbarino JM, et al. Pharmacogenet Genomics. 2014 Mar;24(3):177-83. doi: 10.1097/FPC.0000000000000024. Pharmacogenet Genomics. 2014. PMID: 24492252 Free PMC article. Review. No abstract available.
PharmGKB summary: abacavir pathway.
Barbarino JM, Kroetz DL, Altman RB, Klein TE. Barbarino JM, et al. Pharmacogenet Genomics. 2014 May;24(5):276-82. doi: 10.1097/FPC.0000000000000040. Pharmacogenet Genomics. 2014. PMID: 24625462 Free PMC article. No abstract available.
PharmGKB summary: very important pharmacogene information for MT-RNR1.
Barbarino JM, McGregor TL, Altman RB, Klein TE. Barbarino JM, et al. Pharmacogenet Genomics. 2016 Dec;26(12):558-567. doi: 10.1097/FPC.0000000000000247. Pharmacogenet Genomics. 2016. PMID: 27654872 Free PMC article. Review. No abstract available.
PharmGKB summary: voriconazole pathway, pharmacokinetics.
Barbarino JM, Owusu Obeng A, Klein TE, Altman RB. Barbarino JM, et al. Pharmacogenet Genomics. 2017 May;27(5):201-209. doi: 10.1097/FPC.0000000000000276. Pharmacogenet Genomics. 2017. PMID: 28277330 Free PMC article. No abstract available.
14 results